Swasthya Healthcare Private Limited is a prominent player in the global pharmaceutical landscape, with over 24 years of dedicated service in exporting affordable generic medicines. Focused on enhancing access to high-quality healthcare, Swasthya has established strong partnerships with over 100 manufacturers — both 60n and international — enabling a wide portfolio of finished dosage forms. Its mission is to deliver safe, effective, and economical pharmaceutical solutions to diverse markets, currently exporting to over 28 countries.
During the global pandemic, Swasthya Healthcare stepped up as a critical supplier of life-saving medications, demonstrating its operational resilience, supply chain strength, and commitment to global health. The company’s footprint is bolstered by offices in Dubai, Singapore, and Latin America, affording better responsiveness, regulatory understanding, and distribution capability in these regions.
Led by Directors Arjun Rajesh Deshpande and Rajesh Nandakumar Deshpande, Swasthya Healthcare follows a value-driven, mission-oriented approach. Its strategic focus includes expanding its quality portfolio, maintaining regulatory compliance, and forging long-term relationships with manufacturers and market partners. With consistent participation in international pharma conclaves and trade shows, the company continuously enhances its visibility and credibility. Swasthya Healthcare stands as a trusted partner for global healthcare needs, combining affordability, quality, and global reach in its offerings.